PhRMA lobbies successfully against 'most favored nation' drug pricing law

The pharmaceutical industry, led by PhRMA, will block any congressional effort to pass a law adopting 'most favored nation' drug pricing by 2027. The lobbying effort will focus on Republican opposition to market intervention and Democratic concerns about care rationing.

Implied probability (Yes)

80%